Method for determining D-captopril and captopril-related substances 8 in captopril tablets by adopting high performance liquid chromatography

A technology of high performance liquid chromatography and related substances, applied in the field of drug analysis, can solve the problems of cumbersome operation, effective separation, and poor repeatability, and achieve good repeatability, good precision, and good separation

Active Publication Date: 2020-04-07
SHANGHAI PUKANG PHARMA
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] In the process of research and development of generic captopril tablets, it is necessary to conduct research on D-captopril and captopril related substance 8 of captopril tablets. During the test, it is found that the related substances adopting the European Pharmacopoeia raw material standards When the method was used to determine D-captopril and captopril related substance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for determining D-captopril and captopril-related substances 8 in captopril tablets by adopting high performance liquid chromatography
  • Method for determining D-captopril and captopril-related substances 8 in captopril tablets by adopting high performance liquid chromatography
  • Method for determining D-captopril and captopril-related substances 8 in captopril tablets by adopting high performance liquid chromatography

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] A method for the determination of D-captopril and captopril related substances 8 in captopril tablets by high performance liquid chromatography includes the following steps:

[0043] (1) Preparation of D-captopril, captopril related substances 8 and captopril stock solution

[0044] Weigh 5mg each of D-captopril, captopril related substance 8 and captopril reference substance, put them in a 50mL measuring flask, add absolute ethanol to dissolve and dilute to the mark, shake well, as D-card Topril, captopril related substances 8 and captopril reference substance stock solution;

[0045] (2) Preparation of system suitability solution

[0046] Add step (1) 1.0mL of D-captopril, captopril related substances 8 and captopril stock solution, place in a 10ml measuring flask, dilute to the mark with absolute ethanol, shake well, as system suitability Solution

[0047] (3) Preparation of test solution

[0048] Weigh an appropriate amount of fine captopril tablets (25mg of captopril), plac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Login to view more

Abstract

The invention belongs to the technical field of pharmaceutical analysis, and particularly relates to a method for determining D-captopril and captopril related substances 8 in captopril tablets by adopting high performance liquid chromatography. The method comprises the steps that a test solution containing captopril is detected through adoption of high performance liquid chromatography, captopril, D-captopril and captopril related substances 8 are obtained, wherein the conditions of high performance liquid chromatography detection are as follows: a chromatographic column is an amylose-tri(3,5-xylylcarbamate) coating type chiral chromatographic column, the mobile phase is a mixed solution of n-hexane, isopropanol, methanol and trifluoroacetic acid, the elution mode is isocratic elution. According to the invention, the contents of D-captopril and captopril-related substances 8 in the captopril tablets can be quantitatively determined, so that the quality of the captopril tablets is effectively controlled.

Description

Technical field [0001] The invention belongs to the technical field of drug analysis, and specifically relates to a method for determining D-captopril and captopril related substances 8 in captopril tablets by high performance liquid chromatography. Background technique [0002] Captopril is the first discovered angiotensin converting enzyme inhibitor (ACEI), a synthetic non-peptide compound. Since its appearance in the 1990s, it has shifted from a special drug for the treatment of hypertension and congestive heart failure. Clinical medications for the treatment of other cardiovascular diseases, rheumatoid arthritis, pulmonary hypertension and other diseases have great clinical value. Captopril is also known as (S)-1-(3-mercapto-2-methyl-1-oxopropyl)-L-proline, and its structural formula is shown in the following formula I. [0003] [0004] There are many related substances in captopril in the process of preparation and storage. Only captopril disulfide impurities are specified ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/02G01N30/06G01N30/34G01N30/36G01N30/74
CPCG01N30/02G01N30/06G01N30/34G01N30/36G01N30/74G01N2030/027
Inventor 卢艳赵颖周俊彭娇张伟伟
Owner SHANGHAI PUKANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products